CUE - Cue Biopharma, Inc.
12.455
-5.475 -43.958%
Share volume: 695,667
Last Updated: 04-28-2026
Pharmaceutical Products/Pharmaceutical Preparations:
-0.12%
PREVIOUS CLOSE
CHG
CHG%
$17.93
-5.48
-0.31%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-14-2024 | 11-14-2024 | 05-12-2025 | 08-12-2025 | 11-12-2025 | 03-16-2026 | |
| Assets | ||||||||
| Total Assets | 53.951 M | 42.329 M | 44.810 M | 22.254 M | 40.707 M | 31.644 M | 42.212 M | |
| Current Assets | 44.669 M | 33.900 M | 37.256 M | 15.931 M | 30.844 M | 25.819 M | 36.983 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 912.000 K | 470.000 K | 1.747 M | 1.093 M | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 6.971 M | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 41.029 M | 30.029 M | 32.420 M | 13.136 M | 27.492 M | 11.701 M | 27.136 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 754.000 K | 667.000 K | 570.000 K | 523.000 K | 454.000 K | 307.000 K | 241.000 K | |
| Other Assets | 8.528 M | 7.762 M | 6.984 M | 5.800 M | 9.409 M | 5.518 M | 4.988 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 53.951 M | 42.329 M | 44.810 M | 22.254 M | 40.707 M | 31.644 M | 42.212 M | |
| Total liabilities | 23.913 M | 20.707 M | 19.444 M | 15.674 M | 22.548 M | 18.398 M | 15.780 M | |
| Total current liabilities | 18.090 M | 16.459 M | 16.790 M | 15.498 M | 19.254 M | 15.524 M | 13.494 M | |
| Accounts Payable | 3.919 M | 3.906 M | 6.474 M | 3.784 M | 3.627 M | 2.348 M | 3.948 M | |
| Other liabilities | 2.579 M | 1.962 M | 1.326 M | 176.000 K | 3.104 M | 2.684 M | 2.286 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 3.244 M | 2.286 M | 1.328 M | 0.000 | 190.000 K | 190.000 K | 0.000 | |
| Other liabilities | 2.579 M | 1.962 M | 1.326 M | 176.000 K | 3.104 M | 2.684 M | 2.286 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 30.038 M | 21.622 M | 25.366 M | 6.580 M | 18.159 M | 13.246 M | 26.432 M | |
| Common stock | 343.575 M | 345.330 M | 357.734 M | 360.701 M | 380.762 M | 383.296 M | 394.898 M | |
| Retained earnings | -313.537 M | -323.708 M | -332.368 M | -354.121 M | -362.603 M | -370.051 M | -368.466 M |